Skip to main content
Top
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Cardiovascular mortality among a cohort of hypertensive and normotensives in Rio de Janeiro - Brazil - 1991–2009

Authors: Thiago Luiz Nogueira da Silva, Carlos Henrique Klein, Armando da Rocha Nogueira, Lucia Helena Alvares Salis, Nelson Albuquerque de Souza e Silva, Katia Vergetti Bloch

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Although there is strong evidence of the benefits of antihypertensive treatment, the high prevalence of this important cardiovascular risk factor and its complications, as well as the low control rates of hypertension observed in many studies justify the investigation of these relationships in population studies. The objective was to investigate the ratio of cardiovascular disease mortality between hypertensives (non-treated, controlled and uncontrolled) and non-hypertensives in a cohort of a population sample of adults living in Ilha do Governador, Rio de Janeiro state, Brazil, who were classified in a survey conducted in 1991 and 1992 and whose death certificates were sought 19 years later.

Methods

A cohort study was performed on probabilistic linkage between data from an epidemiological study of hypertension performed in Ilha do Governador, in Rio de Janeiro, Brazil (1991 to 1992) and data from the Mortality Information System of Rio de Janeiro (1991 to 2009). The survey aimed to estimate the prevalence of hypertension and other cardiovascular risk factors in 1,270 adults aged 20 years or older selected through a probabilistic sampling of households at three economic levels (low, middle and high income). We performed a probabilistic record linkage of these databases and estimated the risk of cardiovascular death using Kaplan-Meier method to plot survival curves and Cox proportional hazards models comparing hypertensive subjects all together, and by hypertension subgroups: untreated, controlled, and uncontrolled hypertensives with non-hypertensive ones.

Results

A total of 170 deaths occurred, of which 31.2 % attributed to cardiovascular causes. The hazard ratio for cardiovascular death was 6.1 times higher (95 % CI 2.7 – 13.7) in uncontrolled hypertensive patients relative to non-hypertensive patients. The hazard ratios for untreated hypertensive and controlled hypertensive patients were 2.7 times (95 % CI 1.1 – 6.3) and 2.1 times (95 % CI 0.38 – 11.5) higher than for normotensive patients, respectively.

Conclusion

The present study demonstrated a higher cardiovascular death risk among hypertensive than among non-hypertensive ones that is not associated uniquely to treatment, because uncontrolled hypertensives demonstrated a greater risk than untreated ones. Although the subgroups of hypertensive individuals were susceptible to changes in their classification over the 19 years of the study, the baseline classification was consistent with a worse prognosis in these individuals.
Literature
2.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.CrossRefPubMed
3.
go back to reference Sociedade Brasileira de Cardiologia / Sociedade Brasileira de Hipertensão / Sociedade Brasileira de Nefrologia. VI Diretrizes Brasileiras de Hipertensão. Arq Bras Cardiol. 2010;95:I–III. Sociedade Brasileira de Cardiologia / Sociedade Brasileira de Hipertensão / Sociedade Brasileira de Nefrologia. VI Diretrizes Brasileiras de Hipertensão. Arq Bras Cardiol. 2010;95:I–III.
4.
go back to reference Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–60.CrossRefPubMed Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–60.CrossRefPubMed
5.
go back to reference Egan BM, Zhao Y, Axon RN. US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988–2008. JAMA J Am Med Assoc. 2010;303:2043–50.CrossRef Egan BM, Zhao Y, Axon RN. US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988–2008. JAMA J Am Med Assoc. 2010;303:2043–50.CrossRef
7.
go back to reference Brasil, Ministério da Saúde, Organização Pan-Americana da Saúde. Avaliação do plano de reorganização da atenção à Hipertensão Arterial e ao Diabetes Mellitus no Brasil. Brasília: Ministério da Saúd; 2004 [Projetos, Programas e Relatório]. Brasil, Ministério da Saúde, Organização Pan-Americana da Saúde. Avaliação do plano de reorganização da atenção à Hipertensão Arterial e ao Diabetes Mellitus no Brasil. Brasília: Ministério da Saúd; 2004 [Projetos, Programas e Relatório].
8.
go back to reference Lessa Í. Epidemiologia da hipertensäo arterial sistêmica e da insuficiência cardíaca no Brasil. Rev Bras Hipertens. 2001;8:383–92. Lessa Í. Epidemiologia da hipertensäo arterial sistêmica e da insuficiência cardíaca no Brasil. Rev Bras Hipertens. 2001;8:383–92.
9.
go back to reference Klein CH, Silva NA de S e, Nogueira A da R, Bloch KV, Campos LHS. Hipertensão Arterial na Ilha do Governador, Rio de Janeiro, Brasil: I. Metodologia. Cad Saúde Pública. 1995, 11:187–201. Klein CH, Silva NA de S e, Nogueira A da R, Bloch KV, Campos LHS. Hipertensão Arterial na Ilha do Governador, Rio de Janeiro, Brasil: I. Metodologia. Cad Saúde Pública. 1995, 11:187–201.
10.
go back to reference Jorge MHP M, Laurenti R, Gotlieb SLD. Análise da qualidade das estatísticas vitais brasileiras: a experiência de implantação do SIM e do SINASC. Ciênc Amp Saúde Coletiva. 2007;12:643–54. Jorge MHP M, Laurenti R, Gotlieb SLD. Análise da qualidade das estatísticas vitais brasileiras: a experiência de implantação do SIM e do SINASC. Ciênc Amp Saúde Coletiva. 2007;12:643–54.
11.
go back to reference Camargo Jr KR, Coeli CM. Reclink: aplicativo para o relacionamento de bases de dados, implementando o método probabilistic record linkage. Cad Saúde Pública. 2000;16:439–47. Camargo Jr KR, Coeli CM. Reclink: aplicativo para o relacionamento de bases de dados, implementando o método probabilistic record linkage. Cad Saúde Pública. 2000;16:439–47.
12.
go back to reference Capuani L, Bierrenbach AL, Abreu F, Takecian PL, Ferreira JE, Sabino EC, et al. Accuracy of a probabilistic record-linkage methodology used to track blood donors in the Mortality Information System database. Cad Saúde Pública. 2014;30:1623–32.CrossRefPubMedPubMedCentral Capuani L, Bierrenbach AL, Abreu F, Takecian PL, Ferreira JE, Sabino EC, et al. Accuracy of a probabilistic record-linkage methodology used to track blood donors in the Mortality Information System database. Cad Saúde Pública. 2014;30:1623–32.CrossRefPubMedPubMedCentral
13.
go back to reference Coutinho ESF, Coeli CM. Acurácia da metodologia de relacionamento probabilístico de registros para identificação de óbitos em estudos de sobrevida. Cad Saúde Pública. 2006;22:2249–52.CrossRefPubMed Coutinho ESF, Coeli CM. Acurácia da metodologia de relacionamento probabilístico de registros para identificação de óbitos em estudos de sobrevida. Cad Saúde Pública. 2006;22:2249–52.CrossRefPubMed
14.
go back to reference Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. J Am Stat Assoc. 1958;53:457.CrossRef Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. J Am Stat Assoc. 1958;53:457.CrossRef
15.
go back to reference Peto R, Peto J. Asymptotically Efficient Rank Invariant Test Procedures. J R Stat Soc Ser Gen. 1972;135:185.CrossRef Peto R, Peto J. Asymptotically Efficient Rank Invariant Test Procedures. J R Stat Soc Ser Gen. 1972;135:185.CrossRef
16.
go back to reference Cox DR. Regression Models and Life-Tables. J R Stat Soc Ser B Methodol. 1972;34:187–220. Cox DR. Regression Models and Life-Tables. J R Stat Soc Ser B Methodol. 1972;34:187–220.
17.
go back to reference Soares GP, Brum JD, Oliveira GMM, Klein CH, Souza e Silva NA. Mortalidade por doenças isquêmicas do coração, cerebrovasculares e causas mal definidas nas regiões do estado do Rio de Janeiro, 1980–2007. Rev SOCERJ. 2009;22:142–50. Soares GP, Brum JD, Oliveira GMM, Klein CH, Souza e Silva NA. Mortalidade por doenças isquêmicas do coração, cerebrovasculares e causas mal definidas nas regiões do estado do Rio de Janeiro, 1980–2007. Rev SOCERJ. 2009;22:142–50.
18.
go back to reference Soares GP, Brum JD, de Oliveira GMM, Klein CH, e Silva NAS. Evolução de indicadores socioeconômicos e da mortalidade cardiovascular em três estados do Brasil. Arq Bras Cardiol. 2013;100:147–56.CrossRefPubMed Soares GP, Brum JD, de Oliveira GMM, Klein CH, e Silva NAS. Evolução de indicadores socioeconômicos e da mortalidade cardiovascular em três estados do Brasil. Arq Bras Cardiol. 2013;100:147–56.CrossRefPubMed
19.
go back to reference Czernichow S, Zanchetti A, Turnbull F, Barzi F, Ninomiya T, Kengne A-P, et al. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. J Hypertens. 2011;29:4–16.CrossRefPubMed Czernichow S, Zanchetti A, Turnbull F, Barzi F, Ninomiya T, Kengne A-P, et al. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. J Hypertens. 2011;29:4–16.CrossRefPubMed
20.
go back to reference Yano Y, Briasoulis A, Bakris GL, Hoshide S, Wang J-G, Shimada K, et al. Effects of antihypertensive treatment in Asian populations: A meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA). J Am Soc Hypertens. 2014;8:103–16.CrossRefPubMed Yano Y, Briasoulis A, Bakris GL, Hoshide S, Wang J-G, Shimada K, et al. Effects of antihypertensive treatment in Asian populations: A meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA). J Am Soc Hypertens. 2014;8:103–16.CrossRefPubMed
21.
go back to reference Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H, Witteman JCM. Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study The Reykjavik Study. J Hum Hypertens. 2004;18:615–22.CrossRefPubMed Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H, Witteman JCM. Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study The Reykjavik Study. J Hum Hypertens. 2004;18:615–22.CrossRefPubMed
22.
go back to reference Casiglia E, Mazza A, Tikhonoff V, Scarpa R, Guglielmi F, Pessina AC. Arterial hypertension and mortality in the elderly. Am J Hypertens. 2002;15:958–66.CrossRefPubMed Casiglia E, Mazza A, Tikhonoff V, Scarpa R, Guglielmi F, Pessina AC. Arterial hypertension and mortality in the elderly. Am J Hypertens. 2002;15:958–66.CrossRefPubMed
23.
go back to reference Arima H, Murakami Y, Lam TH, Kim HC, Ueshima H, Woo J, et al. Effects of Prehypertension and Hypertension Subtype on Cardiovascular Disease in the Asia-Pacific Region. Hypertension. 2012;59:1118–23.CrossRefPubMed Arima H, Murakami Y, Lam TH, Kim HC, Ueshima H, Woo J, et al. Effects of Prehypertension and Hypertension Subtype on Cardiovascular Disease in the Asia-Pacific Region. Hypertension. 2012;59:1118–23.CrossRefPubMed
25.
go back to reference Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.CrossRefPubMedPubMedCentral Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.CrossRefPubMedPubMedCentral
26.
go back to reference Hamilton M, Thompson EN, Wisniewski TKM. THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION. Lancet. 1964;283:235–8.CrossRef Hamilton M, Thompson EN, Wisniewski TKM. THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION. Lancet. 1964;283:235–8.CrossRef
27.
go back to reference Wolff FW, Lindeman RD. Effects of treatment in hypertension results of a controlled study. J Chronic Dis. 1966;19:227–40.CrossRefPubMed Wolff FW, Lindeman RD. Effects of treatment in hypertension results of a controlled study. J Chronic Dis. 1966;19:227–40.CrossRefPubMed
28.
go back to reference Brandão AP, Brandão AA, Magalhães MEC, Freitas MEV, Zilli EC, França M de F et al. O impacto do tratamento da hipertensão arterial além do controle da pressão arterial: benefício real ou potencial?; The impact of the treatment of hypertension beyond the control of the arterial pressure: real or potential benefit?. Rev SOCERJ. 2003, 16:43–51. Brandão AP, Brandão AA, Magalhães MEC, Freitas MEV, Zilli EC, França M de F et al. O impacto do tratamento da hipertensão arterial além do controle da pressão arterial: benefício real ou potencial?; The impact of the treatment of hypertension beyond the control of the arterial pressure: real or potential benefit?. Rev SOCERJ. 2003, 16:43–51.
29.
go back to reference Staessen JA, Wang J-G, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305–15.CrossRefPubMed Staessen JA, Wang J-G, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305–15.CrossRefPubMed
30.
go back to reference He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002;16:761–70.CrossRefPubMed He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002;16:761–70.CrossRefPubMed
31.
go back to reference Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens. 2006;24:215–33.CrossRefPubMed Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens. 2006;24:215–33.CrossRefPubMed
32.
go back to reference Lv J, Neal B, Ehteshami P, Ninomiya T, Woodward M, Rodgers A, et al. Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis. PLoS Med. 2012;9. Lv J, Neal B, Ehteshami P, Ninomiya T, Woodward M, Rodgers A, et al. Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis. PLoS Med. 2012;9.
33.
go back to reference Cushman WC. The Burden of Uncontrolled Hypertension: Morbidity and Mortality Associated With Disease Progression. J Clin Hypertens. 2003;5:14–22.CrossRef Cushman WC. The Burden of Uncontrolled Hypertension: Morbidity and Mortality Associated With Disease Progression. J Clin Hypertens. 2003;5:14–22.CrossRef
34.
go back to reference Zanchetti A. Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced? J Hypertens. 2009;27:1509–20.CrossRefPubMed Zanchetti A. Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced? J Hypertens. 2009;27:1509–20.CrossRefPubMed
35.
go back to reference Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H, Witteman JCM. Hypertension Control as Predictor of Mortality in Treated Men and Women, Followed for up to 30 Years. Cardiovasc Drugs Ther. 2005;19:227–35.CrossRefPubMed Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H, Witteman JCM. Hypertension Control as Predictor of Mortality in Treated Men and Women, Followed for up to 30 Years. Cardiovasc Drugs Ther. 2005;19:227–35.CrossRefPubMed
37.
go back to reference Costa E de A, Rose GA, Klein CH, Leal M do C, Szwarcwald CL, Bassanesi SL et al. Salt and blood pressure in Rio Grande do Sul, Brazil. Bull Pan Am Health Organ. 1990, 24:159–76. Costa E de A, Rose GA, Klein CH, Leal M do C, Szwarcwald CL, Bassanesi SL et al. Salt and blood pressure in Rio Grande do Sul, Brazil. Bull Pan Am Health Organ. 1990, 24:159–76.
38.
go back to reference Costa E de A, Rose G, Klein CH, Achutti AC: Diastolic pressure as an index of salt sensitivity. J Hum Hypertens. 1994, 8:703–9. Costa E de A, Rose G, Klein CH, Achutti AC: Diastolic pressure as an index of salt sensitivity. J Hum Hypertens. 1994, 8:703–9.
39.
go back to reference Papadakis S, Moroz I. Population-level interventions for coronary heart disease prevention: what have we learned since the North Karelia project? Curr Opin Cardiol. 2008;23:452–61.CrossRefPubMed Papadakis S, Moroz I. Population-level interventions for coronary heart disease prevention: what have we learned since the North Karelia project? Curr Opin Cardiol. 2008;23:452–61.CrossRefPubMed
40.
go back to reference Souza e Silva NA. Saúde cardiovascular na era tecnológica. Arq Bras Cardiol. 2004;83:453–5. Souza e Silva NA. Saúde cardiovascular na era tecnológica. Arq Bras Cardiol. 2004;83:453–5.
41.
go back to reference Laurenti R, Mello Jorge MHP, Gotlieb SLD: A confiabilidade dos dados de mortalidade e morbidade por doenças crônicas não-transmissíveis. Ciênc Amp Saúde Coletiva. 2004, 9:909–20. Laurenti R, Mello Jorge MHP, Gotlieb SLD: A confiabilidade dos dados de mortalidade e morbidade por doenças crônicas não-transmissíveis. Ciênc Amp Saúde Coletiva. 2004, 9:909–20.
42.
go back to reference Oliveira GMM, Souza e Silva NAS, Klein CH. Mortalidade compensada por doenças cardiovasculares no período de 1980 a 1999 - Brasil. Arq Bras Cardiol. 2005, 85:305–13. Oliveira GMM, Souza e Silva NAS, Klein CH. Mortalidade compensada por doenças cardiovasculares no período de 1980 a 1999 - Brasil. Arq Bras Cardiol. 2005, 85:305–13.
43.
go back to reference Fonseca MGP, Coeli CM, Lucena FFA, Veloso VG, Carvalho MS. Accuracy of a probabilistic record linkage strategy applied to identify deaths among cases reported to the Brazilian AIDS surveillance database. Cad Saúde Pública. 2010, 26:1431–8. Fonseca MGP, Coeli CM, Lucena FFA, Veloso VG, Carvalho MS. Accuracy of a probabilistic record linkage strategy applied to identify deaths among cases reported to the Brazilian AIDS surveillance database. Cad Saúde Pública. 2010, 26:1431–8.
Metadata
Title
Cardiovascular mortality among a cohort of hypertensive and normotensives in Rio de Janeiro - Brazil - 1991–2009
Authors
Thiago Luiz Nogueira da Silva
Carlos Henrique Klein
Armando da Rocha Nogueira
Lucia Helena Alvares Salis
Nelson Albuquerque de Souza e Silva
Katia Vergetti Bloch
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1999-4

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue